The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Abstract
The diagnosis and treatment of neurological ailments always remain an utmost challenge for research fraternity due to the presence of BBB. The intranasal route appeared as an attractive and alternative route for brain targeting of therapeutics without the intrusion of BBB and GI exposure. This route directly and effectively delivers the therapeutics to different regions of the brain via olfactory and trigeminal nerve pathways. However, shorter drug retention time and mucociliary clearance curtail the efficiency of the intranasal route. The in situ mucoadhesive gel overthrow the limitations of direct nose-to-brain delivery by not only enhancing nasal residence time but also minimizing the mucociliary clearance and enzymatic degradation. This delivery system further improves the nasal absorption as well as bioavailability of drugs in the brain. The in situ mucoadhesive gel is a controlled and sustained release system that facilitates the absorption of various proteins, peptides and other larger lipophilic and hydrophilic moieties. Owing to multiple benefits, in situ gelling system has been widely explored to target the brain via nasal route. However, very few review works are reported which explains the application of in situ nasal gel for brain delivery of CNS acting moieties. Hence, in this piece of work, we have initially discussed the global statistics of neurological disorders reported by WHO and other reputed organizations, nasal anatomy, mechanism and challenges of nose-to-brain drug delivery. The work mainly focused on the use of different stimuli-responsive polymers, specifically thermoresponsive, pH-responsive, and ion triggered systems for the development of an effective and controlled dosage form, i.e., in situ nasal gel for brain targeting of bioactives. We have also highlighted the origin, structure, nature and phase transition behavior of the smart polymers found suitable for nasal administration, including poloxamer, chitosan, EHEC, xyloglucan, Carbopol, gellan gum and DGG along with their application in the treatment of neurological disorders. The article is aimed to gather all the information of the past 10 years related to the development and application of stimuli-responsive in situ nasal gel for brain drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ahmad, N., Ahmad, R., Naqvi, A. A., Alam, A., Ashafaq, M., Rub, R. A., & Ahmad, F. J. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1337024 · Cited by 76
RetractedFeigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Alexandridis, P., & Alan Hatton, T. (1995) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/0927-7757(94)03028-x · Cited by 1,920
In situ-forming hydrogels--review of temperature-sensitive systems
Ruel-Gariépy, E., & Leroux, J.-C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.019 · Cited by 1,297
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Molecular Basis of Ca2+-Induced Gelation in Alginates and Pectins: The Egg-Box Model Revisited
Braccini, I., & Pérez, S. (2001) · Biomacromolecules · doi:10.1021/bm010008g · Cited by 1,125
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Role of the Immune system in chronic pain
Marchand, F., Perretti, M., & McMahon, S. B. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1700 · Cited by 1,098
Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,026
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Artificial skin I. Preparation and properties of pluronic F‐127 gels for treatment of burns
Schmolka, I. R. (1972) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820060609 · Cited by 894
Polyaniline-Grafted Reduced Graphene Oxide for Efficient Electrochemical Supercapacitors
Kumar, N. A., Choi, H.-J., Shin, Y. R., Chang, D. W., Dai, L., & Baek, J.-B. (2012) · ACS Nano · doi:10.1021/nn204688c · Cited by 892
(2016) · London School of Economics and Political Science Research Online (London School of Economics and Political Science) · Cited by 874
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Neurological Disorders: Public Health Challenges
Vardi, G., & Merrick, J. (2008) · Journal of Policy and Practice in Intellectual Disabilities · doi:10.1111/j.1741-1130.2007.00143.x · Cited by 762
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Mechanism of intranasal drug delivery directly to the brain
Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Intranasal Drug Delivery: How, Why and What For?
Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3nc79 · Cited by 641
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Self-citationNanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions
Chenite, A. (2001) · Carbohydrate Polymers · doi:10.1016/s0144-8617(00)00281-2 · Cited by 548
Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier
Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 528
Millan, M. J., Gobert, A., Lejeune, F., Dekeyne, A., Newman-Tancredi, A., Pasteau, V., Rivet, J.-M., & Cussac, D. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051797 · Cited by 516
Harkema, J. R., Carey, S. A., & Wagner, J. G. (2006) · Toxicologic Pathology · doi:10.1080/01926230600713475 · Cited by 511
Nanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482
Nasal mucociliary clearance as a factor in nasal drug delivery
Marttin, E., Schipper, N. G. M., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00059-8 · Cited by 469
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Permeability issues in nasal drug delivery
Arora, P., Sharma, S., & Garg, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02452-2 · Cited by 426
Intranasal drug delivery: An efficient and non-invasive route for systemic administration
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L.-J., Le Guen, M., Fischler, M., & Devillier, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.003 · Cited by 398
Grasdalen, H., & Smidsrød, O. (1987) · Carbohydrate Polymers · doi:10.1016/0144-8617(87)90004-x · Cited by 392
A Review on Central Nervous System Effects of Gastrodin
Liu, Y., Gao, J., Peng, M., Meng, H., Ma, H., Cai, P., Xu, Y., Zhao, Q., & Si, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00024 · Cited by 387
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030159 · Cited by 368
Wilson, B., Samanta, M. K., Santhi, K., Kumar, K. P. S., Paramakrishnan, N., & Suresh, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.039 · Cited by 363
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360
Insights into Direct Nose to Brain Delivery: Current Status and Future Perspective
Mittal, D., Ali, A., Md, S., Baboota, S., Sahni, J. K., & Ali, J. (2014) · Drug Delivery · doi:10.3109/10717544.2013.838713 · Cited by 359
Agrawal, M., Ajazuddin, Tripathi, D. K., Saraf, S., Saraf, S., Antimisiaris, S. G., Mourtas, S., Hammarlund-Udenaes, M., & Alexander, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.019 · Cited by 356
Self-citationThe biopharmaceutical aspects of nasal mucoadhesive drug delivery
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775145 · Cited by 355
Wu, J., Wei, W., Wang, L.-Y., Su, Z.-G., & Ma, G.-H. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.024 · Cited by 336
Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering
Crompton, K. E., Goud, J. D., Bellamkonda, R. V., Gengenbach, T. R., Finkelstein, D. I., Horne, M. K., & Forsythe, J. S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.044 · Cited by 332
Physical Gelation of Chitosan in the Presence of β-Glycerophosphate: The Effect of Temperature
Cho, J., Heuzey, M.-C., Bégin, A., & Carreau, P. J. (2005) · Biomacromolecules · doi:10.1021/bm050313s · Cited by 329
In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate
El-Kamel, A. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00234-x · Cited by 320
Resveratrol nanoformulations: Challenges and opportunities
Summerlin, N., Soo, E., Thakur, S., Qu, Z., Jambhrunkar, S., & Popat, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.003 · Cited by 316
Bioavailability oftrans-resveratrol from red wine in humans
Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C., Caporaso, N., Vescovi, P. P., Fogliano, V., & Marchelli, R. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500002 · Cited by 313
R. Neves, A., Lucio, M., L.C. Lima, J., & Reis, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945085 · Cited by 313
Effects of physicochemical properties and other factors on systemic nasal drug delivery
Behl, C. R., Pimplaskar, H. K., Sileno, A. P., deMeireles, J., & Romeo, V. D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00063-x · Cited by 312
Thirawong, N., Nunthanid, J., Puttipipatkhachorn, S., & Sriamornsak, P. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.010 · Cited by 305
Zhang, Q., Jiang, X., Jiang, W., Lu, W., Su, L., & Shi, Z. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.039 · Cited by 286
Carbopol/pluronic phase change solutions for ophthalmic drug delivery
Lin, H.-R., & Sung, K. C. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00329-1 · Cited by 282
Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository
Choi, H.-G., Jung, J.-H., Ryu, J.-M., Yoon, S.-J., Oh, Y.-K., & Kim, C.-K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00386-4 · Cited by 281
Jung, Y.-S., Park, W., Park, H., Lee, D.-K., & Na, K. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.08.068 · Cited by 268
Almeida, H., Amaral, M. H., Lobão, P., & Lobo, J. M. S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.001 · Cited by 257
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
Peuskens, J., & Link, C. G. G. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb10162.x · Cited by 251
Kim, S., Nishimoto, S. K., Bumgardner, J. D., Haggard, W. O., Gaber, M. W., & Yang, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.139 · Cited by 247
Structural analysis of xyloglucans in the primary cell walls of plants in the subclass Asteridae
Hoffman, M., Jia, Z., Peña, M. J., Cash, M., Harper, A., Blackburn, A. R., Darvill, A., & York, W. S. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.04.016 · Cited by 232
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Patel, R. J., Ajazuddin, Ravichandiran, V., Murty, U. S., & Alexander, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.020 · Cited by 230
Self-citationThermoreversible-mucoadhesive Gel for nasal delivery of sumatriptan
Majithiya, R. J., Ghosh, P. K., Umrethia, M. L., & Murthy, R. S. R. (2006) · AAPS PharmSciTech · doi:10.1208/pt070367 · Cited by 228
A new view of pectin structure revealed by acid hydrolysis and atomic force microscopy
Round, A. N., Rigby, N. M., MacDougall, A. J., & Morris, V. J. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2009.12.019 · Cited by 224
Buspirone: What is it all about?
Loane, C., & Politis, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.032 · Cited by 222
Polysaccharide drug delivery systems based on pectin and chitosan
Morris, G. A., Kök, S. M., Harding, S. E., & Adams, G. G. (2010) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2010.10648153 · Cited by 222
Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations
Rogers, J. M., & Panegyres, P. K. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.02.006 · Cited by 221
Chatterjee, B., Gorain, B., Mohananaidu, K., Sengupta, P., Mandal, U. K., & Choudhury, H. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.032 · Cited by 216
Zaki, N. M., Awad, G. A., Mortada, N. D., & Abd ElHady, S. S. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.08.006 · Cited by 214
Zangara, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00111-4 · Cited by 208
On the physicochemical properties of gellan gum
Milas, M., Shi, X., & Rinaudo, M. (1990) · Biopolymers · doi:10.1002/bip.360300322 · Cited by 206
CHEN, J., SWOPE, D., & DASHTIPOUR, K. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.021 · Cited by 206
ATTWOOD, D., COLLETT, J., & TAIT, C. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90197-8 · Cited by 204
Determination of baseline human nasal pH and the effect of intranasally administered buffers
Washington, N., Steele, R. J. C., Jackson, S. J., Bush, D., Mason, J., Gill, D. A., Pitt, K., & Rawlins, D. A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00442-1 · Cited by 200
Evidence of nose-to-brain delivery of nanoemulsions: Cargoes but not vehicles
Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., et al. (2017) · Nanoscale · doi:10.1039/c6nr07581a · Cited by 194
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications
Soliman, K. A., Ullah, K., Shah, A., Jones, D. S., & Singh, T. R. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.036 · Cited by 189
Intranasal Mucoadhesive Microemulsions of Clonazepam: Preliminary Studies on Brain Targeting
Vyas, T. K., Babbar, A. K., Sharma, R. K., Singh, S., & Misra, A. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20480 · Cited by 186
The global burden of neurological disorders
Carroll, W. M. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30029-8 · Cited by 182
Bhavna, Md, S., Ali, M., Ali, R., Bhatnagar, A., Baboota, S., & Ali, J. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.03.022 · Cited by 181
Hinchcliffe, M., & Illum, L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00073-8 · Cited by 180
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
Desai, S. D., & Blanchard, J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970090e · Cited by 177
Smart materials: in situ gel-forming systems for nasal delivery
Karavasili, C., & Fatouros, D. G. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.10.016 · Cited by 175
Development of in situ gel for nasal delivery: design, optimization,in vitro and in vivo evaluation
Galgatte, U. C., Kumbhar, A. B., & Chaudhari, P. D. (2014) · Drug Delivery · doi:10.3109/10717544.2013.849778 · Cited by 174
Recent expansions of novel strategies towards the drug targeting into the brain
Alexander, A., Agrawal, M., Uddin, A. N. M. S., Siddique, S., Shehata, A. M., Shaker, M. A., Rahman, S. A. U., Abdul, M. I. M., & Shaker, M. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210876 · Cited by 166
Self-citationPharmacokinetic Optimisation in the Treatment of Parkinson???s Disease: An Update
Nyholm, D. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00001 · Cited by 164
Sharma, S., Lohan, S., & Murthy, R. S. R. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.789051 · Cited by 163
Neurotoxicity of nanoscale materials
Karmakar, A., Zhang, Q., & Zhang, Y. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.012 · Cited by 162
Niranjan, R., Koushik, C., Saravanan, S., Moorthi, A., Vairamani, M., & Selvamurugan, N. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.11.026 · Cited by 162
Comprehensive review on additives of topical dosage forms for drug delivery
Garg, T., Rath, G., & Goyal, A. K. (2015) · Drug Delivery · doi:10.3109/10717544.2013.879355 · Cited by 161
Yuan, Y., Cui, Y., Zhang, L., Zhu, H.-P., Guo, Y.-S., Zhong, B., Hu, X., Zhang, L., Wang, X., & Chen, L. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.054 · Cited by 160
Hao, J., Zhao, J., Zhang, S., Tong, T., Zhuang, Q., Jin, K., Chen, W., & Tang, H. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.011 · Cited by 160
Van Woensel, M., Wauthoz, N., Rosière, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S., & De Vleeschouwer, S. (2013) · Cancers · doi:10.3390/cancers5031020 · Cited by 158
Oral zolmitriptan is effective in the acute treatment of cluster headache
Bahra, A., Gawel, M. J., Hardebo, J. E., Millson, D. S., Breen, S. A., & Goadsby, P. J. (2000) · Neurology · doi:10.1212/wnl.54.9.1832 · Cited by 156
Gabal, Y. M., Kamel, A. O., Sammour, O. A., & Elshafeey, A. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.025 · Cited by 155
Youssef, N. A. H. A., Kassem, A. A., Farid, R. M., Ismail, F. A., EL-Massik, M. A. E., & Boraie, N. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.014 · Cited by 153
Marttin, E., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997878 · Cited by 147
In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases
Aderibigbe, B. A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020040 · Cited by 146
Microspheres as nasal drug delivery systems
Pereswetoff-Morath, L. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00069-0 · Cited by 145
Zupancic, M. J., & Guilleminault, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620120-00003 · Cited by 142
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
Solomon, G. D., Cady, R. K., Klapper, J. A., Earl, N. L., Saper, J., & Ramadan, N. M. (1997) · Neurology · doi:10.1212/wnl.49.5.1219 · Cited by 141
Influence of pectin structure on texture of pectin–calcium gels
Fraeye, I., Colle, I. J. P., Vandevenne, E., Duvetter, T., Buggenhout, S. V., Moldenaers, P., Loey, A. M. V., & Hendrickx, M. (2009) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.08.015 · Cited by 139
Sumatriptan nasal spray for the acute treatment of migraine
RYAN, R. E., Elkind, A. H., Baker, C. C., Mullican, W. S., DeBussey, S., & Asgharnejad, M. (1997) · Neurology · doi:10.1212/wnl.49.5.1225 · Cited by 138
Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa
Pund, S., Rasve, G., & Borade, G. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.029 · Cited by 137
In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane
Kaur, P., Garg, T., Rath, G., & Goyal, A. K. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1012260 · Cited by 137
Temperature dependence of the formation and melting of pectin–Ca2+ networks: a rheological study
Cardoso, S. M., Coimbra, M. A., & Lopes‐da‐Silva, J. A. (2003) · Food Hydrocolloids · doi:10.1016/s0268-005x(03)00101-2 · Cited by 135
Qian, S., Wong, Y. C., & Zuo, Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.015 · Cited by 135
An update on the role of nanovehicles in nose-to-brain drug delivery
Feng, Y., He, H., Li, F., Lü, Y., Qi, J., & Wu, W. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.005 · Cited by 134
Meng, X., Liu, J., Yu, X., Li, J., Lu, X., & Shen, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03123-y · Cited by 128
Kadam, Y., Yerramilli, U., Bahadur, A., & Bahadur, P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.10.041 · Cited by 126
Patil, R. P., Pawara, D. D., Gudewar, C. S., & Tekade, A. R. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1552703 · Cited by 124
A review of rivastigmine: A reversible cholinesterase inhibitor
Williams, B. R., Nazarians, A., & Gill, M. A. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80160-1 · Cited by 122
Uptake of exogenous proteins in mouse olfactory cells
Kristensson, K., & Olsson, Y. (1971) · Acta Neuropathologica · doi:10.1007/bf00688493 · Cited by 121
PecSys:in situgelling system for optimised nasal drug delivery
Watts, P., & Smith, A. M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939135 · Cited by 117
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
Kanwar, J. R., Sriramoju, & Kanwar (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s30919 · Cited by 115
Chassenieux, C., & Tsitsilianis, C. (2016) · Soft Matter · doi:10.1039/c5sm02710a · Cited by 115
Chen, X., Zhi, F., Jia, X., Zhang, X., Ambardekar, R., Meng, Z., Paradkar, A. R., Hu, Y., & Yang, Y. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12043 · Cited by 111
Ahmad, S., Ellis, J. C., Kamwendo, H., & MOLYNEUX, E. M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68696-0 · Cited by 111
Sakloetsakun, D., Hombach, J., & Bernkop‐Schnürch, A. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.060 · Cited by 109
In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
Movia, D., Bruni-Favier, S., & Prina‐Mello, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00549 · Cited by 109
Crosslinkable PEO-PPO-PEO-based reverse thermo-responsive gels as potentially injectable materials
Sosnik, A., Cohn, D., Román, J. S., & Abraham, G. A. (2003) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856203763572680 · Cited by 106
Basu, S., & Bandyopadhyay, A. K. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9477-x · Cited by 105
Kumar, P., Sharma, G., Kumar, R., Singh, B., Malik, R., Katare, O. P., & Raza, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.024 · Cited by 105
Self-citationAgrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Hamano, N., Li, S., Chougule, M. B., Shoyele, S., Gupta, U. D., Ajazuddin, M., et al. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1471058 · Cited by 104
Self-citationWavikar, P., Pai, R. V., & Vavia, P. R. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.08.024 · Cited by 103
Leyva-Gómez, G., Cortés, H., Magaña, J. J., Leyva-García, N., Quintanar-Guerrero, D., & Florán, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.009 · Cited by 102
Gutierrez, M. A., Stimmel, G. L., & Aiso, J. Y. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80210-2 · Cited by 102
Shelke, S., Shahi, S., Jalalpure, S. S., & Dhamecha, D. L. (2016) · Journal of Liposome Research · doi:10.3109/08982104.2015.1132232 · Cited by 101
Ahirrao, M., & Shrotriya, S. N. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1338721 · Cited by 101
Samaridou, E., Walgrave, H., Salta, E., Álvarez, D. M., Castro-López, V., Loza, M. I., & Alonso, M. J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119657 · Cited by 101
Destruel, P.-L., Zeng, N., Maury, M., Mignet, N., & Boudy, V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.12.008 · Cited by 100
Ravi, P. R., Aditya, N., Patil, S. B., & Cherian, L. (2013) · Drug Delivery · doi:10.3109/10717544.2013.860501 · Cited by 99
Intranasal therapeutic strategies for management of Alzheimer’s disease
Sood, S., Jain, K., & Gowthamarajan, K. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2013.876644 · Cited by 99
Rasagiline (TVP-1012): A new selective monoamine oxidase inhibitor for Parkinson's disease
Guay, D. R. P. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.12.001 · Cited by 97
Rivastigmine-loadedin situgelling nanostructured lipid carriers for nose to brain delivery
Wavikar, P., & Vavia, P. R. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.954129 · Cited by 94
Brain and other nervous system disorders across the lifespan — global challenges and opportunities
Silberberg, D. H., Anand, N. P., Michels, K. M., & Kalaria, R. N. (2015) · Nature · doi:10.1038/nature16028 · Cited by 94
Wang, Z., Gu, J., Wang, X., Xie, K., Luan, Q., Wan, N., Zhang, Q., Jiang, H., & Liu, D. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.007 · Cited by 93
Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer’s disease
Bastiat, G., Plourde, F., Motulsky, A., Fürtös, A., Dumont, Y., Quirion, R., Fuhrmann, G., & Leroux, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.009 · Cited by 91
A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus
Cock, H. R., & Schapira, A. H. V. (2002) · QJM · doi:10.1093/qjmed/95.4.225 · Cited by 88
Mucoadhesivein situnasal gelling drug delivery systems for modulated drug delivery
Singh, R. M. P., Kumar, A., & Pathak, K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.746659 · Cited by 87
Tejada, G., Barrera, M. G., Piccirilli, G. N., Sortino, M. A., Frattini, A., Salomon, C. J., Lamas, M. C., & Leonardi, D. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0720-6 · Cited by 86
Rajput, A., Bariya, A. H., Allam, A. A., Othman, S. I., & Butani, S. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0540-6 · Cited by 86
Morphology and gelation of thermosensitive xyloglucan hydrogels
Nisbet, D. R., Crompton, K. E., Hamilton, S., Shirakawa, S., Prankerd, R. J., Finkelstein, D. I., Horne, M. K., & Forsythe, J. S. (2006) · Biophysical Chemistry · doi:10.1016/j.bpc.2005.12.005 · Cited by 85
Thermally reversible xyloglucan gels as vehicles for oral drug delivery
Kawasaki, N., Ohkura, R., Miyazaki, S., et al. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00026-5 · Cited by 85
Krauland, A. H., Leitner, V. M., & Bernkop‐Schnürch, A. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10371 · Cited by 84
Formulation and Evaluation of Thermosensitive Biogels for Nose to Brain Delivery of Doxepin
Naik, A. A., & Nair, H. A. (2014) · BioMed Research International · doi:10.1155/2014/847547 · Cited by 83
Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease
Rao, M. R. P., Agrawal, D. K., & Shirsath, C. (2016) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2016.1225754 · Cited by 83
Redox Solid Energy Boosters for Flow Batteries: Polyaniline as a Case Study
Zanzola, E., Dennison, C. R., Battistel, A., Peljo, P., Vrubel, H., Amstutz, V., & Girault, H. H. (2017) · Electrochimica Acta · doi:10.1016/j.electacta.2017.03.084 · Cited by 83
Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Pallàs, M., Porquet, D., Vicente, A., & Sanfeliu, C. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380005 · Cited by 81
Charlton, S. T., Davis, S. S., & Illum, L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.014 · Cited by 81
Formulation and Evaluation of In Situ Gelling Systems for Intranasal Administration of Gastrodin
Cai, Z., Song, X., Sun, F., Yang, Z., Hou, S., & Liu, Z. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9678-y · Cited by 79
Intranasal mucociliary clearance of putative bioadhesive polymer gels
Zhou, M. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04441-9 · Cited by 78
Nystroem, B., Walderhaug, H., Hansen, F., et al. (1995) · Langmuir · doi:10.1021/la00003a014 · Cited by 78
Alexander, A., & Saraf, S. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241458 · Cited by 78
Self-citationCyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies
Yang, T., Hussain, A., Paulson, J. R., Abbruscato, T. J., & Ahsan, F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032998.84488.7a · Cited by 77
Morilla, M. J., Perez, A. P., Mundinio, C., & Romero, E. L. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28261 · Cited by 77
Intranasal Administration of Drugs
Scheibe, M., Bethge, C., Witt, M., & Hummel, T. R. (2008) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.134.6.643 · Cited by 76
Fatouh, A. M., Elshafeey, A. H., & Abdelbary, A. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1357148 · Cited by 74
Solid lipid nanoparticles loaded with lipoyl–memantine codrug: Preparation and characterization
Laserra, S., Basit, A., Sozio, P., Marinelli, L., Fornasari, E., Cacciatore, I., Ciulla, M., Türkez, H., Geyikoglu, F., & Di Stefano, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.001 · Cited by 72
New and future migraine therapy
Ramadan, N. M., & Buchanan, T. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.010 · Cited by 72
The Pharmacokinetics of Venlafaxine When Given in a Twice‐Daily Regimen
Troy, S. M., Parker, V. D., Fruncillo, R. J., & Chiang, S. T. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04081.x · Cited by 71
Salatin, S., Barar, J., Barzegar-Jalali, M., Adibkia, K., & Jelvehgari, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.031 · Cited by 71
Insulin mediated novel therapies for the treatment of Alzheimer's disease
Dubey, S. K., Lakshmi, K. K., Krishna, K. V., Agrawal, M., Singhvi, G., Saha, R. N., Saraf, S., Saraf, S., Shukla, R., & Alexander, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117540 · Cited by 68
Self-citationSherje, A. P., & Londhe, V. Y. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0844-8 · Cited by 65
Xie, H., Li, L., Sun, Y., Wang, Y., Gao, S., Tian, Y., Ma, X., Guo, C., Bo, F., & Zhang, L. (2019) · Nanomaterials · doi:10.3390/nano9020147 · Cited by 65
Formulation and Evaluation of Niosomal Nasal Drug Delivery System of Folic Acid for Brain Targeting
Ravouru, N., Kondreddy, P., Korakanchi, D., & Haritha, M. M. (2013) · Current Drug Discovery Technologies · doi:10.2174/15701638113109990031 · Cited by 64
Sridhar, V., Wairkar, S., Gaud, R. S., Bajaj, A., & Meshram, P. V. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1350858 · Cited by 64
Dubey, S. K., Munnangi, S. R., Krishna, K. V., Saha, R. N., Singhvi, G., Agrawal, M., Ajazuddin, M., Saraf, S., Saraf, S., & Alexander, A. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00653-z · Cited by 64
Self-citationDevelopment and evaluation of in situ nasal gel formulations of loratadine.
Sherafudeen, S. P., & Vasantha, P. V. (2015) · Europe PMC (PubMed Central) · Cited by 63
Fisher, A., Watling, M. I. L., Smith, A., & Knight, A. (2010) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp48138 · Cited by 62
Smart polymers in nasal drug delivery
Udupa, N., Chonkar, A. D., & Nayak, U. Y. (2015) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.164770 · Cited by 62
Jarry, C., Leroux, J., Haeck, J., et al. (2002) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.50.1335 · Cited by 61
Receptor-Binding and Pharmacokinetic Properties of Dopaminergic Agonists
Kvernmo, T., Houben, J. M., & Sylte, I. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785161457 · Cited by 61
Lee, J. B., Yoon, J. J., Lee, D. S., & Park, T. G. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562042459751 · Cited by 61
Gothwal, A., Nakhate, K. T., Alexander, A., Ajazuddin, M., & Gupta, U. D. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00537 · Cited by 59
Self-citationZhao, Y., Fu, B., Zhang, X., Zhao, T., Chen, L., Zhang, J., & Wang, X. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.09.008 · Cited by 58
Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels
Li, X., Du, L., Chen, X., Ge, P., Wang, Y., Fu, Y., Sun, H., Jiang, Q., & Jin, Y. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.009 · Cited by 56
Injectable in situ Physically and Chemically Crosslinkable Gellan Hydrogel
Du, H., Hamilton, P. D., Reilly, M. A., & Ravi, N. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100422 · Cited by 56
Zolmitriptan Orally Disintegrating Tablet is Effective in the Acute Treatment of Migraine
Dowson, A., MacGregor, E. A., Purdy, R. A., et al. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00319.x · Cited by 56
Shi, X., Chen, Y., Liu, H., & Qu, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5573 · Cited by 55
Paliperidone ER: a review of the clinical trial data
Janicak, P. G. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1365 · Cited by 54
Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting
Jose, S., Ansa, C. R., Cinu, T. A., Chacko, A. J., Aleykutty, N., Ferreira, S. V., & Souto, E. B. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.049 · Cited by 54
Kumar, P., Sharma, G., Kumar, R., Malik, R., Singh, B., Katare, O. P., & Raza, K. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00428 · Cited by 54
Self-citationRNAi therapeutics for CNS disorders
Boudreau, R. L., & Davidson, B. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.038 · Cited by 53
In Situ Gel-Forming System: An Attractive Alternative for Nasal Drug Delivery
Wang, X., Liu, G., Ma, J., Guo, S., Gao, L., Jia, Y., Li, X., & Zhang, Q. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013007362 · Cited by 52
Effects of Tetrahydroaminoacridine on Liver Function in Patients with Alzheimer's Disease
O'Brien, J. T., EGGER, S., & Levy, R. (1991) · Age and Ageing · doi:10.1093/ageing/20.2.129 · Cited by 52
Pharmacokinetics of Gastrodin in rat plasma and CSF after i.n. and i.v.
Wang, Q., Chen, G., & Zeng, S. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.041 · Cited by 51
Yates, R., Nairn, K., Dixon, R., et al. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127002762491325 · Cited by 50
Karlsson, L., Schmitt, U., Josefsson, M., Björn Carlsson, A., Ahlner, J., Bengtsson, F., Kugelberg, F. C., & Hiemke, C. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.04.004 · Cited by 49
Nikisch, G., Baumann, P., Liu, T., & Mathé, A. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001556 · Cited by 48
Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges
Vitorino, C., Silva, S., Bicker, J., Falcão, A. C., & Fortuna, A. C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.001 · Cited by 48
Viscoelastic properties of aqueous gellan solutions: the effects of concentration on gelation
Nakamura, K., Harada, K., & Tanaka, Y. (1993) · Food Hydrocolloids · doi:10.1016/s0268-005x(09)80239-7 · Cited by 47
Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats
Zhao, Y. H., Peng, Y. U. E., Tao, T. A. O., & Chen, Q. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00486.x · Cited by 46
Hoskin, K. L., Lambert, G. A., Donaldson, C., & Zagami, A. S. (2003) · Brain Research · doi:10.1016/j.brainres.2003.11.018 · Cited by 44
Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway
Vaka, S. R. K., Murthy, S. N., Balaji, A., & Repka, M. A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0572-9 · Cited by 43
Toxicological Implications of Nasal Formulations
Quadir, M. A., Zia, H., & Needham, T. E. (1999) · Drug Delivery · doi:10.1080/107175499266823 · Cited by 43
Pichard‐Garcia, L., Hyland, R., Baulieu, J., Fabre, J., Milton, A., & Maurel, P. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15002-7 · Cited by 41
Salatin, S., Alami-Milani, M., Daneshgar, R., & Jelvehgari, M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1483387 · Cited by 39
Raval, A., Parmar, A., Raval, A., & Bahadur, P. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.12.034 · Cited by 38
Individual Triptan Selection in Migraine Attack Therapy
Belvís, R., Pagonabarraga, J., & Kulisevsky, J. (2008) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909787002555 · Cited by 36
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Overcoming barriers by local drug delivery with liposomes
Antimisiaris, S. G., Marazioti, A., Kannavou, M., Natsaridis, E., Gkartziou, F., Kogkos, G., & Mourtas, S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.019 · Cited by 339
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Koo, J., Lim, C., & Oh, K. T. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s439181 · Cited by 174
Metadata
- Authors
- Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., Murty, U. S., Ajazuddin, & Alexander, A.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 327
- Pages
- 235-265
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3046258544
- Cited by
- 298
- References
- 220
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.